Form 13-F position report

APREA THERAPEUTICS INC

Reported by OLD POINT TRUST & FINANCIAL SERVICES N A

APRE CUSIP 03836J201 Manager CIK 0001102256

Reported 0 shares, down 50 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q2 2024
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 2 Through Q2 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2024-03-31 335
2024-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

2 quarters
Quarterly reported position history for APREA THERAPEUTICS INC held by OLD POINT TRUST & FINANCIAL SERVICES N A.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2024 Reduced 0 -50 (-100.0%) 0 $0 2024-08-13
Q1 2024 New 50 +50 (0.0%) < 0.01% $335 2024-05-14

Who else reported the position

30 managers reported APREA THERAPEUTICS INC for Q2 2024.

Managers reporting APREA THERAPEUTICS INC in Q2 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
AIGH Capital Management LLC Unchanged 539,300 0 0.68% $2,194,951 6 qtrs
Sio Capital Management LLC Unchanged 276,603 0 0.3% $1,125,774 6 qtrs
SPHERA FUNDS MANAGEMENT LTD Unchanged 270,000 0 0.15% $1,098,900 2 qtrs
Nantahala Capital Management LLC Unchanged 205,760 0 0.05% $837,443 2 qtrs
Altium Capital Management LP New 137,197 +137,197 0.23% $558,392 1 qtr
DAFNA Capital Management LLC Unchanged 137,174 0 0.13% $558,298 2 qtrs
Exome Asset Management LLC New 137,174 +137,174 0.5% $558,298 1 qtr
Stonepine Capital Management LLC New 137,174 +137,174 0.51% $558,298 1 qtr
VANGUARD GROUP INC Reduced 115,838 -140 < 0.01% $471,461 6 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 35,673 +15,452 < 0.01% $145,215 5 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2024
Filed
August 13, 2024
Filing type
13F-HR
Position type
Com

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.